Citation Impact
Citing Papers
Cancer treatment and survivorship statistics, 2022
2022 Standout
Testicular cancer
2018
The tor pathway: a target for cancer therapy
2004 Standout
Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database
2015
Placental-like alkaline phosphatase and DNA flow cytometry in spermatocytic seminoma
1992
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
2003 StandoutNobel
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Spermatocytic seminoma: An immunohistochemical study
1994
Skin Cancers after Organ Transplantation
2003 Standout
Natural products for cancer chemotherapy
2010 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Colorectal cancer
2019 Standout
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Testicular germ-cell tumours in a broader perspective
2005 Standout
Vascular endothelial growth factor in eye disease
2008 Standout
Recent global trends in testicular cancer incidence and mortality
2018
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Silybin and silymarin - new effects and applications
2005 Standout
Consensus Statement on Management of Intersex Disorders
2006 Standout
Spermatocytic seminoma
1994
Defining the Role of mTOR in Cancer
2007 Standout
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Familial testicular cancer and second primary cancers in testicular cancer patients by histological type
2001
Spermatocytic Seminoma: A Review
2003
Silymarin and skin cancer prevention: Anti-inflammatory, antioxidant and immunomodulatory effects (Review)
2005
Testicular Cancer Survivorship
2019
Chromosomal constitution of human spermatocytic seminomas: Comparative genomic hybridization supported by conventional and interphase cytogenetics
1998
Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review)
2010
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins
2005 StandoutNobel
Carcinoma in situ in the Testis
2000
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of D Ondruš being referenced
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
2014
Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer
2009
The Incidence of Tumours in Renal Transplant Recipients with Long-Term Immunosuppressive Therapy
1999
The incidence of carcinoma in situ in postpubertal undescended testis
1987
Metastatic spermatocytic seminoma. A case report with light microscopic, ultrastructural, and immunohistochemical findings
1988
Epidemiology and treatment delay in testicular cancer patients: a retrospective study
2007
Do we know the cause of the highest colorectal cancer incidence, the changes in the mortality trends and the clinical stages in the Slovak and Czech Republic, the representatives of the Central European region?
2011
Familial testicular cancer and developmental anomalies.
1997
Epidemiology of testicular tumors in the Slovak Republic.
2005